Beam Therapeutics, Inc. (BEAM)
24.27
-0.39
(-1.58%)
USD |
NASDAQ |
Sep 25, 16:00
24.24
-0.03
(-0.12%)
After-Hours: 19:59
Beam Therapeutics Cash and Short Term Investments (Annual) : 1.245B for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 1.245B |
| December 31, 2024 | 850.74M |
| December 31, 2023 | 1.190B |
| December 31, 2022 | 1.078B |
| December 31, 2021 | 965.65M |
| Date | Value |
|---|---|
| December 31, 2020 | 299.67M |
| December 31, 2019 | 91.85M |
| December 31, 2018 | 146.44M |
| December 31, 2017 | 1.901M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| Intellia Therapeutics, Inc. | 449.88M |
| Twist Bioscience Corp. | 232.43M |
| Prime Medicine, Inc. | 177.68M |
| Q32 Bio, Inc. | 48.30M |
| Sarepta Therapeutics, Inc. | 939.65M |